Involvement of lncRNAs and Macrophages: Potential Regulatory Link to Angiogenesis

Yang Jia1, Yedi Zhou2,3

  • 1Department of Pediatrics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.

Insights

Long noncoding RNAs (lncRNAs) regulate macrophages in angiogenesis, offering potential therapeutic targets for diseases like cancer and diabetic retinopathy. This review explores lncRNA roles in macrophage-mediated pathological angiogenesis.

Area of Science:

  • Molecular Biology
  • Immunology
  • Pathology

Background:

  • Macrophages play a crucial role in angiogenesis, vital for tissue repair and organ development.
  • Dysfunctional angiogenesis contributes to diseases like malignant tumors and diabetic retinopathy.
  • Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in cellular processes and disease pathogenesis.

Purpose of the Study:

  • To review the involvement of lncRNAs associated with macrophages in angiogenesis.
  • To discuss the mechanisms by which lncRNAs regulate macrophage functions in angiogenesis.
  • To explore the therapeutic potential of targeting lncRNA-macrophage interactions in angiogenesis-related diseases.

Main Methods:

  • Literature review of studies on lncRNAs, macrophages, and angiogenesis.
  • Analysis of mechanisms underlying lncRNA regulation of macrophage infiltration and polarization.
  • Discussion of lncRNA involvement in pathological angiogenesis in various diseases.

Main Results:

  • lncRNAs modulate macrophage infiltration and polarization, impacting angiogenesis.
  • lncRNAs influence the secretion of inflammatory cytokines by macrophages.
  • Specific lncRNAs are implicated in the pathogenesis of angiogenesis-related diseases.

Conclusions:

  • lncRNA-macrophage interactions are critical in regulating angiogenesis.
  • Targeting these interactions presents a promising therapeutic strategy for angiogenesis-related diseases.
  • Further research into lncRNA mechanisms can advance treatments for conditions like cancer and diabetic retinopathy.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K